Earth Science Tech anticipates registration of the trademark for the product will be approved within 10 months Company is conducting a pre-launch clinical study of the product in Quebec, Canada, with Clinique Santé Amitié Line…
Aligns with AATAC to reach up to 90,000 retail outlets A new reliable source and manufacturing plant was worth the wait Three new unique chocolate products announced Earth Science Tech, Inc. (OTC: ETST), an innovative…
ETST is in the process of trademarking and finalizing packaging for a medical device designed to detect sexually transmitted infections The biotech company is focused on developing medical devices for the pharmaceutical and nutraceutical fields…
Updates on CBD patents and medical device progress Working to improve medical treatments on a global scale through its subsidiaries Moving toward uplisting to the OTCQB Venture Market Earth Science Tech, Inc. (OTC: ETST), based…
Quebec grant will help develop its cannabinoid products; ETST testing will commence in 4Q2018 on formula patents aimed at preventing cancer and other diseases ETST will apply for trademark, finalize packaging for debut of medical…
Over the last three weeks, leaders from ETST have attended four cannabis expos in Canada and the U.S. Events included the Lift and Co. Expo, which is the biggest cannabis expo in Canada, as well…
Earth Science Tech (OTC: ETST), an innovative biotech company focused on the cannabidiol (“CBD”), nutraceutical and pharmaceutical fields, this morning provided an update regarding its ongoing CBD formula patents and medical device progress. Per the…
Earth Science Tech, Inc. (OTC: ETST), an innovative biotech company focused on the cannabidiol (“CBD”), nutraceutical and pharmaceutical fields, this morning released a report recapping its presence at four recent cannabis expos in Canada and…
ETST issues new audio press release regarding its audits, Form 10, financing plans and fully reporting status ETST has started 2017 fiscal year audit, which is required, along with the approved Form 10, to uplist…
Innovative biotech company Earth Science Tech (OTC: ETST) is employing its state-of-the-art technology to produce the highest-grade full spectrum hemp oil for product formulation amid rising demand in the cannabidiol (“CBD”) sector. An article discussing…
Earth Science Tech (OTC: ETST), an innovative biotech company focused on the cannabidiol (“CBD”), nutraceutical and pharmaceutical fields as well as medical devices and research and development, is poised to gain its share of the…
Company recently announced that its 2015 and 2016 YE audits have been finalized, its Form 10 has been submitted and it has commenced its 2017 fiscal year audit Strategically working to improve treatments for different…
ETST now begins 2017 fiscal year audit, which is required along with the approved Form 10 to uplist to the OTCQB Biotech company is focused on developing medical devices for the pharmaceutical and nutraceutical fields…
Earth Science Tech (OTC: ETST), an innovative biotech company focused on the cannabidiol (CBD), nutraceutical and pharmaceutical fields as well as medical devices and research and development, this morning announced that its audit process has…
With a strong team in place, Earth Science Tech, Inc. (OTC: ETST) is well on its way to becoming a licensed distributor and bringing its products to the Canadian marketplace. Discussing the company’s strong team…
CBD segment projected to grow to $2.1 billion by 2020 Global hemp-based foods market forecast to grow at a CAGR of 24 percent from 2018 to 2022 ETST uses cutting-edge technology to produce the highest-grade…
12 more U.S. states likely to approve medicinal or recreational use of cannabis in 2018 Hemp-derived CBD market on course for CAGR of 55 percent over next five years Ventures in both MMJ and recreational…
Earth Science Tech (OTC: ETST), an innovative biotech company focused on the cannabidiol (“CBD”), nutraceutical and pharmaceutical fields, anticipates completion of white paper studies in early 2019, with clinical trials to follow. An article discussing…
Centers for Disease Control and Prevention, in March 2018, estimated ‘economic burden’ of opioid misuse at $78.5 billion annually ETST plans to complete white paper, begin human clinical trials by 2019; company intends to investigate…
Innovative biotech company Earth Science Tech (OTC: ETST), through its partnership with Laboratories BNK Canada, Inc., is advancing toward commercialization of its new testing services. An article discussing the company reads: “Through ETST’s connection with…